Approval of Tivdak was based on promising results from a Phase III innovaTV 301 clinical trial, which demonstrated a 30% ...

Treatment marks the first dissolving stent approved in the United States for treating chronic limb-threatening ischemia in ...

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity ...

Jennifer Hawks Bland, CEO of NewYorkBIO, spoke with Pharmaceutical Executive about current market trends that investors are ...

Approval of Libervant marks the first orally administered rescue medication for this age group to be cleared by the FDA for ...

Hercessi marks Accord BioPharma’s first biosimilar to be approved in the United States, with multiple indications for ...

Blankenship, vice president of policy initiatives and advocacy at The Academy of Nutrition and Dietetics, discusses how AOMs ...

The lawsuit, filed the department of labor, alleges that Blue Cross improperly collected provider taxes from self-funded ...

Beqvez, a one-time gene therapy, offers hope to patients with moderate to severe hemophilia B who use regular factor IX ...

CVS Health announced that it is opening a workforce development and community center in Louisiana. 1 The center will be ...

In an interview with Pharm Exec Associate Editor Don Tracy, Howard Berman, Chairman, CEO, Coya Therapeutics offers a look at ...

In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses ...